ACTIVE

MEDIFARM+

Financial year 2025 · closed on 30/09/2025
Net result
136,1 k €
-28.4% YoY
Gross margin
611,7 k €
-21.1% YoY
Equity
255,4 k €
+8.5% YoY
Workforce
5,8 ETP
-7.9% YoY

What does MEDIFARM+ do?

MEDIFARM+ is a Public limited company incorporated in 2015. Its registered office is in Brugge. It employs on average 5,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0629.857.424
Incorporation
24/04/2015
Legal form
Public limited company
Registered office
Daverlostraat 110
8310 Brugge · FlandreSee on map
Contributed capital
62 358,00 €
Latest accounts
30/09/2025
Average workforce
5,8 ETP
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 10 financial years

2025202420232022202120202019201820172016
Income statement
Gross margin611,7 k €775,2 k €385,2 k €439,1 k €327,6 k €307,2 k €286,2 k €274,4 k €311,2 k €360,3 k €
EBITDA282,1 k €346,2 k €54,8 k €150 k €51,3 k €92 k €75,5 k €61,9 k €50,9 k €127,2 k €
Operating result164,6 k €229 k €46,7 k €141,6 k €44,3 k €84,5 k €73,2 k €56,9 k €44,4 k €115,1 k €
Net result136,1 k €190,1 k €89,7 k €100,6 k €33,7 k €59,3 k €49,6 k €36,4 k €28,6 k €78,4 k €
Balance sheet
Equity255,4 k €235,3 k €305,2 k €269,6 k €223,2 k €243,6 k €238,5 k €188,9 k €201,7 k €248,7 k €
Total assets2,8 M €2,4 M €2,6 M €2,5 M €676,5 k €688,1 k €653,3 k €773,5 k €755,9 k €757 k €
Cash232,3 k €140,2 k €144,1 k €138,4 k €112,5 k €116,6 k €120,6 k €216,5 k €243,8 k €253,5 k €
Debts2,5 M €2,2 M €2,3 M €2,2 M €453,3 k €444,5 k €414,9 k €584,5 k €554,2 k €508,4 k €
Other
Workforce5,8 ETP6,3 ETP4,5 ETP4,6 ETP4,6 ETP4,0 ETP3,5 ETP3,8 ETP4,7 ETP4,3 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation
Governance

Board of directors

Seen on filing of 30/09/2025 · 2 active · 1 ended

Active mandates

LIKAVER INVEST

Director · 0472.034.365

Represented by Nathalie Verschuere

Active
Nathalie Verschuere

Director

Active

Ended mandates

LIKAVER INVEST

Manager · 0472.034.365

Represented by Nathalie Verschuere

Ended
At this address

Other companies at this address

CompanyCBE no.
MEDIFARMActive
0432.880.514
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/10/202401/10/202301/10/202201/10/202101/10/202001/10/2019
Closing of the financial year30/09/202530/09/202430/09/202330/09/202230/09/202130/09/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/04/202610/06/202530/04/202428/04/202321/03/202226/02/2021
General meeting30/04/202628/05/202518/03/202424/02/202325/02/202226/02/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

11 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model30/09/202530/04/202630/04/2026DutchPDF
Abridged model30/09/202428/05/202510/06/2025DutchPDF
Abridged model30/09/202318/03/202430/04/2024DutchPDF
Abridged model30/09/202224/02/202328/04/2023DutchPDF
Abridged model30/09/202125/02/202221/03/2022DutchPDF
Abridged model30/09/202026/02/202126/02/2021DutchPDF
Abridged model30/09/201928/02/202013/03/2020DutchPDF
Abridged model30/09/201822/02/201918/03/2019DutchPDF
Abridged model30/09/201723/02/201826/03/2018DutchPDF
Abridged model30/09/201624/02/201723/03/2017DutchPDF
Abridged model30/09/201526/02/201625/03/2016DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/09/2025 · 2 active · 1 ended

Active mandates

LIKAVER INVEST

Director · 0472.034.365

Represented by Nathalie Verschuere

Active
Nathalie Verschuere

Director

Active

Ended mandates

LIKAVER INVEST

Manager · 0472.034.365

Represented by Nathalie Verschuere

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Restructuring12/06/2024
    KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring20/10/2023
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - DIVERSEN
    PDF
  • Mandates31/12/2020
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DIVERSEN - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates28/07/2017
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other19/05/2015
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025136,1 k €
  2. 2024
    Annual accounts 2024190,1 k €
  3. 2023
    Annual accounts 202389,7 k €
  4. 2022
    Annual accounts 2022100,6 k €
  5. 2021
    Annual accounts 202133,7 k €
  6. 2020
    Annual accounts 202059,3 k €
  7. 2019
    Annual accounts 201949,6 k €
  8. 2018
    Annual accounts 201836,4 k €
  9. 2017
    Annual accounts 201728,6 k €
  10. 2016
    Annual accounts 201678,4 k €
  11. 24/04/2015
    IncorporationPublic limited company